However, PTX3 also has the inhibitory effect on angiogenesis and is able to moderate malignant progression in bladder cancer (52), multiple myeloma (62), fibrosarcoma (63), and prostate cancer (64). The gene discussed is PTX3; the disease is AL amyloidosis.